Rare Neurological Disease Treatment Market to Grow at a CAGR of 8.5% to reach US$13,830.96 million from 2020 to 2027

    Rare Neurological Disease Treatment Market to 2027 - Global Analysis and Forecasts by Indication (Narcolepsy, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Multiple Sclerosis, Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy, Other Indication); Drug Type (Organic Compounds, Biologics); Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies); Mode of Administration (Oral, Injectables) and Geography

    Publication Month: Mar 2020 | Report Code: TIPRE00008485 | No. of Pages: 183 | Category: Pharmaceuticals | Status: Published

    The rare neurological disease treatment market is expected to reach US$13,830.96 Mn in 2027 from US$ 7,300.12Mn in 2019. The market is estimated to grow with a CAGR of 8.5% from 2020-2027.

    Neurological diseases having less diagnostics and treatment options affecting small number of population is termed as rare neurological diseases. These diseases target the nervous system, which include the brain, spinal cord, and all the nerves that run throughout the human body. Amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy, Huntington's disease are few examples of rare neurological conditions. The global rare neurological disease treatment market is driven by factors such as rising prevalence of rare neurological diseases and favorable pipeline drugs and robust research activities for the treatment of rare neurological diseases. However, high treatment cost for rare neurological diseases are likely to show negative impact on market growth during the forecast period.

    Lucrative Regional Rare Neurological Disease Treatment Markets

    Get more information on this report :



    Market Insights

    Rising Prevalence of Rare Neurological Diseases

    In the world of medicine, rare neurological diseases represent significant burden on health systems in terms of disease diagnosis, treatment, and management. Some of the majorly observed rare neurological diseases comprises narcolepsy, amyotrophic lateral sclerosis, Alzheimer’s disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchenne muscular dystrophy, and others. According to a data published by National Institutes of Neurological Disorders and Stroke in 2019, 7,000 rare neurological diseases have been registered in the US. Additionally, according to the same study, these conditions are responsible for significant number of morbidity and mortality.

    Deprivation of sleep, psychological stress, an inherited genetic fault, sudden change in sleep patterns, and aging are the main factors that accelerate the prevalence of rare neurological diseases. Considering these factors, the elderly population is highly vulnerable for neurological conditions. For instance, as per the study published in Annals of Neurology in 2017, around 100 million US populations was affected by the rare neurological disease in 2011. Moreover, these diseases are responsible to increase the morbidity and disability, which affects the economic condition of the country. Neurological sleep related disorders are expected to increase in coming years owing to the increasing ageing population across the world. According to the data published by National Institute of Health (NIH) in 2019, approximately 40 million Americans suffer from neurological diseases in the US, whereas additional 20 million people experience occasional sleeping problems.

    Indication Insights

    Based on indication, the rare neurological disease treatment market is segmented into narcolepsy, amyotrophic lateral sclerosis, Alzheimer’s disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchene muscular dystrophy, and other indications. The Alzheimer’s disease segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period. The disease accounts for nearly 60% to 80% of all dementia cases and is widely seen among the aging population.

    Global Rare Neurological Disease Treatment Market, by Indication – 2018 & 2027

    Get more information on this report :



    Drug Type Insights

    Based on drug type, the rare neurological disease treatment market is segmented into organic compounds, and biologics. The biologics segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

    Distribution Channel Insights

    Based on distribution channel, the rare neurological disease treatment market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. The hospital pharmacies segment held the largest share of the market in 2019 however, retail pharmacies is estimated to register the highest CAGR in the market during the forecast period.

    Mode of Administration Insights

    Based on mode of administration, the rare neurological disease treatment market is segmented into oral and injectable. The oral segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period

    Strategic Insights

    Product launches and FDA approvals strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.

    The market players operating in the rare neurological disease treatment market adopt the strategy of collaborations to enlarge customer base across the world, which also permits the players to maintain their brand name globally.

    Global Rare Neurological Disease Treatment Market– By Indication

    • Narcolepsy
    • Amyotrophic Lateral Sclerosis
    • Alzheimer’s Disease
    • Multiple Sclerosis
    • Spinal Muscular Atrophy (SMA)
    • Duchenne Muscular Dystrophy
    • Other Indications

    Global Rare Neurological Disease Treatment Market– By Drug Type

    • Organic Compounds
    • Biologics

    Global

    Rare Neurological Disease Treatment Market– By Distribution Channel

    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

    Global Rare Neurological Disease Treatment Market – By Mode of Administration

    • Oral
    • Injectable

    Rare Neurological Disease Treatment Market – By Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of Asia Pacific
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

    Company Profiles

    • Allergan plc
    • Bayer AG
    • GlaxoSmithKline plc
    • Johnson & Johnson Services Inc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Teva Pharmaceutical Industries Ltd
    • Takeda Pharmaceutical

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Rare Neurological Disease Treatment Market– By Indication

    1.3.2 Global Rare Neurological Disease Treatment Market– By Drug Type

    1.3.3 Global Rare Neurological Disease Treatment Market– By Distribution Channel

    1.3.4 Global Rare Neurological Disease Treatment Market – By Mode of Administration

    1.3.5 Global Rare Neurological Disease Treatment Market– By Geography

    2. Rare Neurological Disease Treatment Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Rare Neurological Disease Treatment– Market Landscape

    4.1 Overview

    4.2 Pest Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe– PEST Analysis

    4.2.3 Asia Pacific– PEST Analysis

    4.2.4 Middle East & Africa– PEST Analysis

    4.2.5 South and Central America – PEST Analysis

    5. Rare Neurological Disease Treatment– Key Market Dynamics

    5.1 Key Market Drivers

    5.1.1 Rising Prevalence of Rare Neurological Diseases

    5.1.2 Favourable Pipeline Drugs and Robust Research Activities for the Treatment of Rare Neurological Diseases

    5.2 Key Market Restraints

    5.2.1 High Treatment Cost for Rare Neurological Diseases

    5.3 Key Market Opportunities

    5.3.1 Increasing Awareness of Rare Neurological Diseases Coupled with Developing Healthcare Infrastructure

    5.4 Future Trends

    5.4.1 Artificial Intelligence for the Treatment of Rare Neurological Diseases

    5.5 Impact Analysis

    6. Rare Neurological Disease Treatment Market– Global Analysis

    6.1 Global Rare Neurological Disease Treatment Market Revenue Forecast And Analysis

    6.2 Global Rare Neurological Disease Treatment Market, By Geography - Forecast And Analysis

    6.3 Market Positioning of Key Players

    7. Rare Neurological Disease Treatment Market Analysis – By Indication

    7.1 Overview

    7.2 Rare Neurological Disease Treatment Market Share, by Indication, 2019 and 2027 (%)

    7.3 Narcolepsy

    7.3.1 Overview

    7.3.2 Narcolepsy: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)

    7.4 Amyotrophic Lateral Sclerosis

    7.4.1 Overview

    7.4.2 Amyotrophic Lateral Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)

    7.5 Alzheimer’s Disease

    7.5.1 Overview

    7.5.2 Alzheimer’s Disease: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)

    7.6 Multiple Sclerosis

    7.6.1 Overview

    7.6.2 Multiple Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)

    7.7 Spinal Muscular Atrophy (SMA)

    7.7.1 Overview

    7.7.2 Spinal Muscular Atrophy (SMA): Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    7.8 Duchenne Muscular Dystrophy

    7.8.1 Overview

    7.8.2 Duchenne Muscular Dystrophy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    7.9 Other Indications

    7.9.1 Overview

    7.9.2 Other Indications: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    8. Rare Neurological Disease Treatment Market Analysis – By Drug Type

    8.1 Overview

    8.2 Rare Neurological Disease Treatment Market Share, by Drug Type, 2019 and 2027, (%)

    8.3 Organic Compounds

    8.3.1 Overview

    8.3.2 Organic Compounds: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    8.4 Biologics

    8.4.1 Overview

    8.4.2 Biologics: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    9. Rare Neurological Disease Treatment Market Analysis – By Distribution Channel

    9.1 Overview

    9.2 Rare Neurological Disease Treatment Market Share, by Distribution Channel, 2019 and 2027, (%)

    9.3 Online Pharmacies

    9.3.1 Overview

    9.3.2 Online Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    9.4 Hospital Pharmacies

    9.4.1 Overview

    9.4.2 Hospital Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    9.5 Retail Pharmacies

    9.5.1 Overview

    9.5.2 Retail Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    10. Rare Neurological Disease Treatment Market Analysis – By Mode of Administration

    10.1 Overview

    10.2 Rare Neurological Disease Treatment Market Share, by Mode of Administration, 2019 and 2027 (%)

    10.3 Oral

    10.3.1 Overview

    10.3.2 Oral: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    10.4 Inject able

    10.4.1 Overview

    10.4.2 Inject able: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    11. Rare Neurological Disease Treatment Market – Geographic Analysis

    11.1 North America: Rare Neurological Disease Treatment Market

    11.1.1 Overview

    11.1.2 North America: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.1.3 North America: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.1.4 North America: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.1.5 North America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.1.6 North America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.1.7 North America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)

    11.1.8 US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.1.8.1 US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.1.8.2 US: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.1.8.3 US: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.1.8.4 US: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.1.8.5 US: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.1.9 Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.1.9.1 Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.1.9.2 Canada: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.1.9.3 Canada: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.1.9.4 Canada: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.1.9.5 Canada: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.1.10 Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.1.10.1 Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.1.10.2 Mexico: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.1.10.3 Mexico: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.1.11 Mexico: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.1.11.1 Mexico: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.2 Europe: Rare Neurological Disease Treatment Market

    11.2.1 Overview

    11.2.2 Europe: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)

    11.2.3 Europe: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.2.4 Europe: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.2.5 Europe: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.2.6 Europe: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.2.7 Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)

    11.2.8 Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.8.1 Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.8.2 Germany: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.2.8.3 Germany: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.2.8.4 Germany: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.2.8.5 Germany: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.2.8.6 United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.8.7 United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.8.8 United Kingdom: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.2.8.9 United Kingdom: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.2.8.10 United Kingdom: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.2.8.11 United Kingdom: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.2.9 France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.9.1 France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.9.2 France: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.2.9.3 France: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.2.9.4 France: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.2.9.5 France: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.2.10 Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.10.1 Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.10.2 Spain: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.2.10.3 Spain: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.2.10.4 Spain: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.2.10.5 Spain: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.2.11 Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.11.1 Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.2.11.2 Italy: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.2.11.3 Italy: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.2.11.4 Italy: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.2.11.5 Italy: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.3 Asia Pacific: Rare Neurological Disease Treatment Market

    11.3.1 Overview

    11.3.2 Asia Pacific: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)

    11.3.3 Asia Pacific: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.3.4 Asia Pacific: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.3.5 Asia Pacific: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.3.6 Asia Pacific: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.3.7 Asia Pacific: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)

    11.3.8 China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.3.8.1 China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.3.8.2 China: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.3.8.3 China: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.3.8.4 China: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.3.8.5 China: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.3.9 Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.3.9.1 Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.3.9.2 Japan: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.3.9.3 Japan: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.3.9.4 Japan: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.3.9.5 Japan: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.3.10 India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.3.10.1 India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.3.10.2 India: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.3.10.3 India: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.3.10.4 India: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.3.10.5 India: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.3.11 South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.3.11.1 South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.3.11.2 South Korea: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.3.11.3 South Korea: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.3.11.4 South Korea: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.3.11.5 South Korea: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.3.12 Australia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.3.13 Australia: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.3.13.1 Australia: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.3.13.2 Australia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.3.13.3 Australia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.4 Middle East & Africa: Rare Neurological Disease Treatment Market

    11.4.1 Overview

    11.4.2 Middle East & Africa: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)

    11.4.3 Middle East & Africa: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.4.4 Middle East & Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.4.5 Middle East & Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.4.6 Middle East & Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.4.7 Middle East & Africa: Rare Neurological Disease Treatment Market Share by Country – 2019 & 2027, (%)

    11.4.8 Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.4.8.1 Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.4.8.2 Saudi Arabia: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.4.8.3 Saudi Arabia: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.4.8.4 Saudi Arabia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.4.8.5 Saudi Arabia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.4.9 UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.4.9.1 UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.4.9.2 UAE: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.4.9.3 UAE: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.4.9.4 UAE: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.4.9.5 UAE: Rare Neurological Disease Treatment Market, by Distribution Channel , 2018–2027 (USD Million)

    11.4.10 South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    11.4.10.1 South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.4.10.2 South Africa: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.4.10.3 South Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.4.10.4 South Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.4.10.5 South Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.5 South and Central America: Rare Neurological Disease Treatment Market

    11.5.1 Overview

    11.5.2 South and Central America: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)

    11.5.3 South and Central America: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.5.4 South and Central America: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.5.5 South and Central America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.5.6 South and Central America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.5.7 South and Central America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)

    11.5.8 Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.5.8.1 Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.5.8.2 Brazil: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.5.8.3 Brazil: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.5.8.4 Brazil: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.5.8.5 Brazil: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    11.5.9 Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.5.9.1 Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    11.5.9.2 Argentina: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)

    11.5.9.3 Argentina: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)

    11.5.9.4 Argentina: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)

    11.5.9.5 Argentina: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)

    12. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market

    12.1 North America: Impact Assessment of COVID-19 Pandemic

    12.2 Europe: Impact assessment of COVID-19 Pandemic

    12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

    13. Rare Neurological Disease Treatment Market –Industry Landscape

    13.1 Overview

    13.2 Growth Strategies In The Rare Neurological Disease Treatment Market, 2017-2020

    13.3 Inorganic Growth Strategies

    13.3.1 Overview

    13.4 Organic Growth Strategies

    13.4.1 Overview

    14. Company Profiles

    14.1 Allergan Plc.

    14.1.1 Key Facts

    14.1.2 Business Description

    14.1.3 Products and Services

    14.1.4 Financial Overview

    14.1.5 SWOT Analysis

    14.1.6 Key Developments

    14.2 Bayer AG

    14.2.1 Key Facts

    14.2.2 Business Description

    14.2.3 Products and Services

    14.2.4 Financial Overview

    14.2.5 SWOT Analysis

    14.2.6 Key Developments

    14.3 GlaxoSmithKline plc.

    14.3.1 Key Facts

    14.3.2 Business Description

    14.3.3 Products and Services

    14.3.4 Financial Overview

    14.3.5 SWOT Analysis

    14.3.6 Key Developments

    14.4 Johnson & Johnson Services, Inc.

    14.4.1 Key Facts

    14.4.2 Business Description

    14.4.3 Products and Services

    14.4.4 Financial Overview

    14.4.5 SWOT Analysis

    14.4.6 Key Developments

    14.5 Merck & Co., Inc.

    14.5.1 Key Facts

    14.5.2 Business Description

    14.5.3 Products and Services

    14.5.4 Financial Overview

    14.5.5 SWOT Analysis

    14.5.6 Key Developments

    14.6 Novartis AG

    14.6.1 Key Facts

    14.6.2 Business Description

    14.6.3 Products and Services

    14.6.4 Financial Overview

    14.6.5 SWOT Analysis

    14.6.6 Key Developments

    14.7 Pfizer Inc.

    14.7.1 Key Facts

    14.7.2 Business Description

    14.7.3 Products and Services

    14.7.4 Financial Overview

    14.7.5 SWOT Analysis

    14.7.6 Key Developments

    14.8 Sanofi

    14.8.1 Key Facts

    14.8.2 Business Description

    14.8.3 Products and Services

    14.8.4 Financial Overview

    14.8.5 SWOT Analysis

    14.8.6 Key Developments

    14.9 Teva Pharmaceutical Industries Ltd

    14.9.1 Key Facts

    14.9.2 Business Description

    14.9.3 Products and Services

    14.9.4 Financial Overview

    14.9.5 SWOT Analysis

    14.9.6 Key Developments

    14.10 Takeda Pharmaceutical Company Limited

    14.10.1 Key Facts

    14.10.2 Business Description

    14.10.3 Products and Services

    14.10.4 Financial Overview

    14.10.5 SWOT Analysis

    14.10.6 Key Developments

    15. Appendix

    15.1 About The Insight Partners

    15.2 Glossary of Terms

    LIST OF TABLES

    Table 1. North America Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 2. North America Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 3. North America Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 4. North America Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 5. US Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 6. US Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 7. US Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 8. US Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 9. Canada Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 10. Canada Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 11. Canada Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 12. Canada Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 13. Mexico Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 14. Mexico Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 15. Mexico Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 16. Mexico Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 17. Europe Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 18. Europe Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 19. Europe Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 20. Europe Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 21. Germany Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 22. Germany Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 23. Germany Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 24. Germany Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 25. United Kingdom Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 26. United Kingdom Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 27. United Kingdom Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 28. United Kingdom Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 29. France Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 30. France Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 31. France Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 32. France Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 33. Spain Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 34. Spain Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 35. Spain Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 36. Spain Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 37. Italy Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 38. Italy Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 39. Italy Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 40. Italy Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 41. Asia Pacific Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 42. Asia Pacific Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 43. Asia Pacific Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 44. Asia Pacific Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 45. China Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 46. China Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 47. China Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 48. China Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 49. Japan Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 50. Japan Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 51. Japan Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 52. Japan Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 53. India Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 54. India Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 55. India Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 56. India Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 57. South Korea Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 58. South Korea Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 59. South Korea Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 60. South Korea Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 61. Australia Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 62. Australia Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 63. Australia Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 64. Australia Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 65. Middle East & Africa Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 66. Middle East & Africa Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 67. Middle East & Africa Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 68. Middle East & Africa Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 69. Saudi Arabia Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 70. Saudi Arabia Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 71. Saudi Arabia Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 72. Saudi Arabia Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 73. UAE Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 74. UAE Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 75. UAE Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 76. UAE Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 77. South Africa Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 78. South Africa Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 79. South Africa Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 80. South Africa Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 81. South and Central America Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 82. South and Central America Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 83. South and Central America Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 84. South and Central America Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 85. Brazil Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 86. Brazil Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 87. Brazil Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 88. Brazil Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 89. Argentina Rare Neurological Disease Treatment Market, by Indication – Revenue and Forecast to 2027 (USD Million)

    Table 90. Argentina Rare Neurological Disease Treatment Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

    Table 91. Argentina Rare Neurological Disease Treatment Market, by Mode of Administration – Revenue and Forecast to 2027 (USD Million)

    Table 92. Argentina Rare Neurological Disease Treatment Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 93. Recent Inorganic Growth Strategies In The Rare Neurological Disease Treatment Market

    Table 94. Recent Organic Growth Strategies In The Rare Neurological Disease Treatment Market

    Table 95. Glossary of Terms, Rare Neurological Disease Treatment Market

    LIST OF FIGURES

    Figure 1. Rare Neurological Disease Treatment Market Segmentation

    Figure 2. Rare Neurological Disease Treatment, By Region

    Figure 3. Global Rare Neurological Disease Treatment Market Overview

    Figure 4. Alzheimer’s Disease Segment Held Largest Share Of Indication Segment In Rare Neurological Disease Treatment Market

    Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

    Figure 6. Global Rare Neurological Disease Treatment Market, By Geography (US$ Million)

    Figure 7. Global Rare Neurological Disease Treatment Market- Leading Country Markets (US$ Million)

    Figure 8. Global Rare Neurological Disease Treatment Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia pacific PEST Analysis

    Figure 12. Middle East & Africa PEST Analysis

    Figure 13. South and central America PEST Analysis

    Figure 14. Rare Neurological Disease Treatment Market Impact Analysis Of Driver And Restraints

    Figure 15. Global Rare Neurological Disease Treatment Market– Revenue Forecast And Analysis – 2019- 2027

    Figure 16. Global Rare Neurological Disease Treatment Market– By Geography Forecast And Analysis – 2019- 2027

    Figure 17. Market Positioning Of Key Players In Global Rare Neurological Disease Treatment Market

    Figure 18. Rare Neurological Disease Treatment Market Share, by Indication, 2019 and 2027 (%)

    Figure 19. Narcolepsy: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)

    Figure 20. Amyotrophic Lateral Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)

    Figure 21. Alzheimer’s Disease: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)

    Figure 22. Multiple Sclerosis: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 23. Spinal Muscular Atrophy (SMA): Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 24. Duchenne Muscular Dystrophy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 25. Other Indications: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 26. Rare Neurological Disease Treatment Market Share, by Drug Type, 2019 and 2027 (%)

    Figure 27. Organic Compounds: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 28. Biologics: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 29. Rare Neurological Disease Treatment Market Share, by Distribution Channel, 2019 and 2027 (%)

    Figure 30. Online Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 31. Hospital Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 32. Retail Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 33. Rare Neurological Disease Treatment Market Share, by Mode of Administration, 2019 and 2027 (%)

    Figure 34. Oral: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 35. Injectable: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 36. North America: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)

    Figure 37. North America Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)

    Figure 38. North America: Rare Neurological Disease Treatment Market, by Country, 2019 & 2027 (%)

    Figure 39. US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 40. Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 41. Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 42. Europe: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)

    Figure 43. Europe Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)

    Figure 44. Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)

    Figure 45. Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 46. United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 47. France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 48. Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 49. Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 50. Asia Pacific: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)

    Figure 51. Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)

    Figure 52. China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 53. Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 54. India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 55. South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 56. Australia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 57. Middle East & Africa: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)

    Figure 58. Middle East & Africa Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)

    Figure 59. Middle East & Africa: Rare Neurological Disease Treatment Market Share by Country – 2019 & 2027, (%)

    Figure 60. Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 61. UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

    Figure 62. South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 63. South and Central America: Rare Neurological Disease Treatment Market, by Key Country – Revenue (2019) (USD Million)

    Figure 64. South and Central America Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)

    Figure 65. South and Central America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)

    Figure 66. Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 67. Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)

    Figure 68. Impact of COVID-19 Pandemic In North American Country Markets

    Figure 69. Impact of COVID-19 Pandemic In European Country Markets

    Figure 70. Impact of COVID-19 Pandemic In Asia Pacific Country Markets

    Figure 71. Impact Of COVID-19 Pandemic In North American Country Market

    Figure 72. Growth Strategies in the Rare Neurological Disease Treatment Market, 2017-2020

    The List of Companies - Rare Neurological Disease Treatment Market

    1. Allergan plc
    2. Bayer AG
    3. GlaxoSmithKline plc
    4. Johnson & Johnson Services Inc
    5. Merck & Co. Inc.
    6. Novartis AG
    7. Pfizer Inc.
    8. Sanofi
    9. Teva Pharmaceutical Industries Ltd
    10. Takeda Pharmaceutical
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the rare neurological disease treatment market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global rare neurological disease treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPRE00008485
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Pricing
    • $3000
    • $4550 $3640
    • $6550 $5240
    • $8550 $6840

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst